Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.
NEW YORK, Sept. 3, 2023 /PRNewswire/ — The healthcare IT market in Saudi Arabia size is estimated to increase by USD 1.6032 billion from 2022 to 2027, with a CAGR of 9.06%, according to a recent market study by Technavio. A remarkable increase in the detection of chronic diseases drives…
It was discovered that INFINITT’s Radiology site at Deckerville would initiate echo exams which needed to be sent to Marlette for review by their cardiologists. Marlette already interprets cardiology exams using INFINITT CPACS. After discussing workflow requirements, INFINITT commenced the project without any additional triggers or sales – essentially becoming a mini alliance project.
The tasks involved adding information to templates, setting up connectivity and profiles, training staff, and assisting in workflow determination. Regular updates were provided along with separate calls to ensure a smooth transition for all parties. INFINITT acknowledges that effective partnerships and teamwork are crucial in maintaining an efficient continuum of care with minimal disruptions.
“The INFINITT team has proven to be a phenomenal resource and support for our collaborative networking project. We reached out with a task, and they took the wheel and flawlessly guided us through the whole process. I could not have asked for a smoother transaction,” said Jennifer Hoag, Diagnostic Imaging Supervisor at Deckerville Community Hospital.
INFINITT is all about seamless integrations and taking on the heavy lifting so that both the hospital and staff can focus on what matters, and that’s the health of their patients. Katrina Pandrea Moorehead, Director of Ancillary Services and Cardiopulmonary Manager at Marlette Regional Hospital adds, “Thanks to the exceptional team at INFINITT North America and Deckerville Community Hospital for working together collaboratively with Marlette Regional Hospital to bring Cardiac Echo images from Deckerville Hospital to Marlette Hospital’s CPACS for interpretation. The entire process was handled efficiently through emails and a few Teams meetings. I could not have asked for a better group of people to work with. The process was remarkably easy.”
INFINITT North America (INA) operates in 56 countries, on five continents: with over 6500 installations and counting. INFINITT has been ranked Best-in-KLAS Category Leader for the Community Hospital market and Imaging Center/Ambulatory market over 12 times. INA combines all the tools you need with fast and reliable access to images and data, to make the medical imaging component of your healthcare service model the easiest and smoothest piece of your care coordination plan.
For more information visit:
Media Contact
Shannon Spak, INFINTT North America, 1 877-387-6960, [email protected], https://www.infinittna.com/
SOURCE INFINTT North America
Vasectomy has been a popular method of birth control for men seeking permanent control of their fertility and for couples who want a safer, more effective alternative to female tubal ligation. Vasectomy has seen a dramatic resurgence after the Supreme Court overturned Roe V Wade one year ago. Last year many vasectomy providers saw a significant increase in the number of men seeking vasectomy services. Unfortunately this increase in vasectomy seems to have been temporary and men currently considering vasectomy have returned to their baseline unfounded fears about this common procedure. Despite vasectomy being safer and more effective than tubal ligation, many men express reluctance to have a vasectomy for fear of pain and prolonged recovery. These fears are not helped by negative vasectomy experiences repeatedly shared on social media about procedures gone wrong. Many of these vasectomy horror stories are the result of traditional vasectomy which requires a scalpel to make two skin openings and sutures to close these openings.
His Choice Vasectomy is provided during a single office visit and is one of the most minimally invasive forms of vasectomy.
No needle. During a His Choice Vasectomy, local anesthesia is administered with a pressurized air injector. Air, under slight pressure, is used to push the anesthetic through the skin to numb the vasectomy area. Patients describe the sensation of the administration of the local anesthetic like getting lightly tapped on the skin with a rubber band. The no needle method to provide anesthesia is appealing to men who have a fear of needles.
No scalpel. During a His Choice Vasectomy, a single opening is made in the center of the scrotum. A small skin opening is spread with a no scalpel device. Instead of cutting the skin the natural elasticity of the skin is used to stretch an opening. Each side of the vasectomy can be completed using this single opening. The skin is stretched open during the procedure and the elasticity of the skin causes the skin opening to contract and close within 48 hours. No sutures are required during this vasectomy procedure.
Nothing is removed and it is highly effective. During a His Choice Vasectomy nothing is removed from the body. Men leave the office with the same stuff they came in with. The vasectomy is completed with a hand held thermal cautery device. The divided ends are cauterized and slightly separated. This is one of the most effective forms of vasectomy. Once a patient has a negative semen sample test, his chance of a late failure is approximately 0.05%…or 5 out of every 10,000 men. In comparison, tubal ligation failures can be as high as 1.8% and often result in a life threatening ectopic fallopian tube pregnancy.
Open ended vasectomy technique. The lower end of the vas deferens tubes are allowed to remain open during a His Choice Vasectomy. The lower ends will gradually heal closed and this usually allows for an easier recovery. The open ended vasectomy technique may result in less immediate pain during the healing phase of the vasectomy. Some vasectomy reversal doctors also believe open ended vasectomy may provide more success with vasectomy reversal if the patient seeks vasectomy reversal surgery in the future.
A painless vasectomy. His Choice No Cut Vasectomy can be a near painless experience: both during and after the vasectomy procedure. Most patients arrive for their procedures by themselves because a driver is not required. Most men report their His Choice No Cut Vasectomy as ‘not that bad’ and the average reports of pain are 2 on a 10 point scale 24 hours after the procedure. Most men are back to sexual activity within the first 7 days.
The need for affordable, barrier free vasectomy offered during a single visit is large. Many men do not have health insurance, have high deductible health plans, or have religious based plans that do not cover vasectomy procedures. Many are fearful of vasectomy because of misperceived expectations about pain, recovery, and impact on sexual function.
His Choice No Cut Vasectomy is affordable and is priced within reach of those who do not have vasectomy coverage or those who have high insurance deductibles. The procedure is offered during a single office visit without a consultation so men do not have to miss time from work or suffer unnecessary anxiety as they wait for their consultation and procedure appointments.
His Choice No Cut Vasectomy is easy to obtain and provides men the least amount of pain and quickest path to total recovery. This is truly a vasectomy with a 48 hour recovery. Men can safely have their procedure on a Friday and be back to work on Monday.
After full recovery, most His Choice Vasectomy patients notice an increase in sexual satisfaction because their pain was not as bad as expected and they have confidence they have selected a highly effective method of permanent birth control. Both patients and their partners express relief that they now have a highly effective form of birth control providing them greater freedom after being released from the fear of pregnancy.
About Dr. Matthew Zerden.
Dr. Zerden is Board Certified in Obstetrics and Gynecology. As a specialist in Women’s Health Care, Dr Zerden understands the impact of unplanned pregnancy upon couples. He is motivated to offer barrier free vasectomy to help improve the ability of couples to better control their reproduction. Dr Zerden is leading the growing movement of female reproductive specialists offering vasectomy services to male patients.
In 2023, Dr. Zerden trained in His Choice vasectomy with Dr. Monteith. Dr Zerden opened a vasectomy oriented practice in the Triangle area. His goals are to increase the availability of single visit, reduce barrier vasectomy to more patients in the greater Carolinas.
“The most minimally invasive vasectomy procedure available: no needle, no scalpel, and one skin opening. An entire vasectomy procedure completed during a fifteen-minute office visit using local anesthesia. How much easier can a vasectomy be?” said Dr. Zerden
Media Contact
Dr. Matthew Zerden, His Choice Vasectomy, 1 (919) 328-2303, [email protected], https://hischoicedurham.com/
His Choice No Cut Vasectomy
Dr. Matthew Zerden
1(919) 977-5060
DrZerden@HisChoiceDurham.com
SOURCE His Choice Vasectomy
NEW YORK, Aug. 31, 2023 /PRNewswire/ — The surgical microscope market size is estimated to grow at a CAGR of 11.19% between 2022 and 2027. The market size is forecast to increase by USD 859.77 million. The growing number of cataract surgeries in ambulatory settings is the key factor…
FAIRFAX, Va., Aug. 31, 2023 /PRNewswire/ — Mahesh Jayaraman, MD, an interventional neuroradiologist at Rhode Island Hospital who has led national efforts to improve stroke systems of care, has been named the 2023 president of the Society of NeuroInterventional Surgery (SNIS), the leading…
“Dr. Arbet-Engels is a highly respected and experienced global pharmaceutical executive with keen business acumen honed over more than 20 years serving in complex organizational settings,” said Leslie Loveless, Slone Partners CEO. “We are very pleased to have been able to place him at X4 where we believe his extraordinary drive, passion, and vision – and his proven track record of success – will make a wonderful addition to the company’s leadership team.”
“It was truly a pleasure collaborating with Slone Partners on the placement of Christophe as our new Chief Medical Officer,” said Paula Ragan, Ph.D., President and Chief Executive Officer of X4 Pharmaceuticals, “We very much value our relationship with the Slone team and consider them a valuable ongoing resource to X4 given their deep understanding of and high quality connections within the life science industry.”
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
Media Contact
Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected], www.douggavel.com
SOURCE Slone Partners
“I’ve swum recreationally my entire life, so I was excited to learn that Swim Across America funds the Woman and Infants Hospital labs I work in under Drs. Kate Grive and Nicole James,” said Payton. “Swim Across America’s mission aligns with my values, and its support of our translational research in early-stage breast and gynecologic cancer has been vital.”
Payton sits on Swim Across America’s Rhode Island event planning committee. Earlier this year, she attended the Swim Across America national leadership summit and subsequently joined the associate board, which supports the nonprofit’s mission by fostering student and community engagement through initiatives such as the new College Ambassador Program. At this year’s Rhode Island Swim, Payton will volunteer on the beach before and after she dives in to swim a mile with the One Fin Tunas team captained by Dr. David Edmonson.
“Swim Across America’s annual grant literally supports everything I do, not just supplies and equipment,” noted Payton. “Those funds enabled me to join the lab in 2021 as a full-time graduate student starting a new project on triple-negative breast cancer and immunotherapy. I’m grateful for this experience and proud to be part of the next generation of cancer researchers supported by Swim Across America.”
Payton earned a bachelor’s degree in molecular and cellular biology at University of Arizona and a master’s degree in environmental health at Boston University. Besides her academic studies and cancer research work, she is an avid rower and coordinates science outreach programs for students in under-represented communities.
Since 2010, Swim Across America’s open water charity swim in Rhode Island has raised more than $2 million for cancer research at Women & Infants Hospital of Rhode Island. These funds helped researchers in the Program in Women’s Oncology Center for Biomarkers & Emerging Technology discover a biomarker for ovarian cancer and introduce to clinical practice an algorithm that estimates with specificity the risk of ovarian cancer in women with a pelvic mass. This test is now used worldwide and is a game changer for women with ovarian cancer, which is notoriously difficult to diagnose at an early stage when it is most treatable. To learn more, see Women & Infants Hospital’s impact statement at https://bit.ly/saa-ri-wih23.
Charity Swim Event Details
Swim Across America’s 2023 Rhode Island swim kicks off Saturday, September 9, at 9:30 a.m., with a celebration ceremony followed by ¼-mile, ½-mile, and 1-mile swim waves totaling 650 swimmers. Attending Olympians include Block Cancer founder Elizabeth Beisel, Swim Across America – Rhode Island co-director Alex Meyer, Swim Across America COO Janel Jorgensen McArdle, Swim Across America vice president of partnerships and former world record holder Craig Beardsley, and this year’s event emcee Eric Wunderlich. Women & Infants Hospital reps will include president & COO Shannon Sullivan, Program in Women’s Oncology director Dr. Paul DiSilvestro, Swim Across America-funded principal investigators Kate Grive and Nicole James and others who will staff a cancer information booth.
Other event attractions include merch tents hosted by Swim Across America and onsite sponsors JOLYN Clothing and Gill Marine, disc jockey music courtesy of local fav The Face Show, temporary tattoos, beach games, Coca-Cola donated beverages, snacks compliments of Fulfill Nutrition, and boxed lunches from Gansett Wraps. Learn more, register, or donate at swimacrossamerica.org/rhodeisland.
Swim Across America was founded in 1987 with its first open water event in Long Island Sound. Since that time, the nonprofit organization has raised more than $100 million to fight cancer. In its 36 years of making waves to fight cancer, more than 100,000 swimmers and 150 Olympians have swum the circumference of the earth three times, uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities hold open water swims and hundreds of charity pool swims each year, from Nantucket to under the Golden Gate Bridge, which support innovative cancer research, detection and patient programs.
Swim Across America’s funding of clinical trials for patients helped contribute to four FDA approved life-saving immunotherapy cancer treatments: Yervoy, Opdivo, Tecentriq and Keytruda. In June of last year, a clinical trial at Memorial Sloan Kettering was published in The New England Journal of Medicine that showed a 100 percent success rate in treating patients in a phase 2 clinical trial for advanced rectal cancer with dostarlimab, an immunotherapy treatment produced by GlaxoSmithKline. The clinical trial at Memorial Sloan Kettering was funded by early-stage grant funding from Swim Across America. More than 60 scientific grants are funded each year and there are now ten dedicated Swim Across America Labs at major institutions including: Children’s Healthcare of Atlanta, John Hopkins Medicine Baltimore, Rush University Medical Center Chicago, Baylor Scott & White Charles A. Sammons Cancer Center in Dallas, Memorial Sloan Kettering Cancer Center New York, Infusion Center at Nantucket Cottage Hospital, UCSF Benioff Children’s Hospital Oakland and San Francisco, the Seattle Cancer Care Alliance, The Swim Across America Pediatric Research Lab at Columbia University Medical Center New York, and The Swim Across America Laboratory at Meyer Cancer Center at Weill Cornell Medicine.
About Swim Across America
Swim Across America Inc. (SAA) is dedicated to raising money and awareness for cancer research, prevention and treatment through swimming-related events. With the help of hundreds of volunteers nationwide and past and current Olympians, Swim Across America is helping find a cure for cancer through athleticism, community outreach and direct service. To learn more visit swimacrossamerica.org or follow on Facebook @SwimAcrossAmerica or on Instagram or Twitter @SAASwim.
Media Contact
Jenifer Howard, Swim Across America, 1 203-273-4246, [email protected], http://www.swimacrossamerica.org/rhodeisland
SOURCE Swim Across America
“The goal with these new offerings is to empower individuals at every stage of their fitness journey,” said personal trainer, William Byrd. “From those taking their first steps in strength training to seasoned athletes seeking new challenges, our programs are meticulously crafted to cater to everyone. Plus, our new mobility breathing course adds a refreshing, holistic dimension to traditional fitness routines.”
The release of these programs is a testament to Microdose Fitness’s ongoing mission to revolutionize the fitness industry by bridging the gap between beginner, intermediate, and advanced fitness enthusiasts, while promoting the integration of strength, function, and wellness.
For more information about Microdose Fitness’s new programs, visit www.microdosefitness.com.
About Microdose Fitness
Microdose Fitness provides modern fitness programs that promote physical strength, peak performance, and overall wellbeing. They pride themselves on their innovative approach to fitness, offering carefully tailored programs that cater to all fitness levels.
Media Contact
[email protected], Microdosefitness.com, 1 6175052627, [email protected], Microdosefitness.com
SOURCE Microdosefitness.com
Join Bryan Clayton, Chief Commercial Officer, endpoint Clinical, for the live webinar on Monday, September 18, 2023, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Harnessing the Value of Data to Maximize Your eClinical Assets.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
“In some circumstances, these covariates may be known from the scientific literature. In other cases, it may be useful to use previous studies (e.g., a Phase II trial) to select prognostic covariates or form prognostic indices.”
One such innovative application of the guidance is the use of composite covariates such as Placebell, a placebo prognostic covariate developed by Cognivia.
Join this exclusive webinar to explore the latest FDA guidelines and the remarkable benefits of using prognostic covariates to enhance trial accuracy and improve assay sensitivity while complying with regulatory requirements. With a decade of experience developing prognostic covariates and assisting sponsors with adjustments, Cognivia will help you translate this critically important FDA guidance into practical recommendations for your next trial. The featured speakers will also delve into concrete applications of composite prognostic covariates.
Join experts from Cognivia, Samuel Branders, Data Mining Scientist Director; and Hervé Pagès, Customer Solution Director, for the live webinar on Wednesday, September 6, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Covariate Adjustment in Randomized Clinical Trials Based on Latest FDA Guidance: Application to Composite Covariates.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
